Phase 2 Peritoneal Metastases Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
The Application of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Surface Malignancies
Peritoneal Metastases
The University of Hong Kong60 enrolled1 locationNCT06367270
Recruiting
Phase 2
LM-302 and S-1 Plus Intraperitoneal Paclitaxel With or Without Cadonilimab for Claudin 18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis: a Prospective, Exploratory Study
Peritoneal Metastases From Gastric CancerGastric Cancer Stage IVGastric or Esophagogastric Junction Adenocarcinoma
Ruijin Hospital74 enrolled1 locationNCT07556640
Recruiting
Phase 2
Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal Metastasis
Peritoneal MetastasesGastric Cancer Stage IV
Ruijin Hospital40 enrolled1 locationNCT06519591
Not Yet Recruiting
Phase 2Phase 3
PREDICTORG: A Multicentre Personalised Medicine Approach in the Treatment of Colorectal Peritoneal Metastases
Colorectal Peritoneal Metastases
Peter MacCallum Cancer Centre235 enrolled7 locationsACTRN12624001230549
Recruiting
Phase 2
Serplulimab Combined With FOLFIRI and Bevacizumab in the Treatment of Colon Cancer Peritoneal Metastases
Unresectable Colon Cancer Peritoneal MetastasesPMMR/Ras/BRAF Wild-type
Second Affiliated Hospital, School of Medicine, Zhejiang University30 enrolled1 locationNCT05742425
Recruiting
Phase 2
Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients
Peritoneal CarcinomatosisColo-rectal CancerPeritoneal Metastases+1 more
Michael Bau Mortensen60 enrolled1 locationNCT03280511